This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.KE Johnson , CM Thorpe , CL Sears . The emerging clinical importance of non-O157 shiga toxin-producing Escherichia coli. Clinical Infectious Diseases 2006; 43: 1587–1595.
2.LW Riley , Hemorrhagic colitis associated with a rare Escherichia coli serotype. New England Journal of Medicine 1983; 308: 681–685.
3.MK Viljanen , Outbreak of diarrhea due to Escherichia coli O111:B4 in schoolchildren and adults: association of Vi antigen-like reactivity. Lancet 1990; 336: 831–834.
5.Centers for Disease Control and Prevention.Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM – South Australia, 1995. Morbidity and Mortality Weekly Report 1995; 44: 550–551, 557–558.
6.N Banatvala , Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak. Pediatric Infectious Diseases 1996; 15: 1008–1011.
7.PI Tarr , Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with shiga-toxin producing Escherichia coli O103:H2. New England Journal of Medicine 1996; 335: 635–638.
8.H Karch , Epidemiology of shiga toxin-producing Escherichia coli infections. Diagnostic Microbiology and Infectious Diseases 1999; 34: 229–243.
9.TA McCarthy , Hemolytic-uremic syndrome and Escherichia coli O121 at a lake in Connecticut, 1999. Pediatrics 2001; 108: 59.
10.JT Brooks , Outbreak of shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp. Clinical Infectious Diseases 2004; 38: 190–198.
11.TB Brooks , Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983–2002. Journal of Infectious Diseases 2005; 192: 1422–1429.
12.Centers for Disease Control and Prevention.Laboratory-confirmed non-O157 shiga toxin-producing Escherichia coli – Connecticut, 2000–2005. Morbidity and Mortality Weekly Report 2007; 56: 29–31.
20.M Pulz , Comparison of a shiga-toxin enzyme-linked immunosorbent assay and two types of PCR for the detection of shiga toxin-producing Escherichia coli in human stool specimens. Journal of Clinical Microbiology 2003; 41: 4671–4675.
21.L Beutin , S Zimmermann , K Gleier . Pseudomonas aeruginosa can cause false-positive identification of verotoxin (shiga-like toxin) production by a commercial enzyme immune assay system for the detection of shiga-like toxins (SLTs). Infection 1996; 24: 267–268.
26.AC Voetsch , Laboratory practices for stool-specimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet Sites, 1995–2000. Clinical Infectious Diseases 2004; 38 (Suppl. 3): S190–S197.
27.MB Cohen . Shiga toxin-producing Escherichia coli: two tests are better than one. Journal of Pediatrics 2002; 141: 155–156.
28.NJ Cohen , Identifying shiga toxin-producing Escherichia coli: results of a laboratory evaluation. Foodborne Pathogens and Disease 2008; 5: 295–301.
29.D Hoefer , Laboratory practices for the identification of shiga toxin-producing Escherichia coli in the United States, FoodNet Sites, 2007. Foodborne Pathogens and Disease 2011; 8: 555–560.
30.DJ Bopp , Detection, isolation, and molecular subtyping of Escherichia coli 0157:H7 and Campylobacter jejuni associated with a large waterborne outbreak. Journal of Clinical Microbiology 2003; 41: 174–180.
31.EM Ribot , Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathogens and Disease 2006; 3: 59–67.
35.CS Wong , The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New England Journal of Medicine 2000; 342: 1930–1936.
36.BP Bell , Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997; 100: 12.
37.JA Ake , Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005; 115: 673–680.